Why partner with us

Discover, share, and co-invest in vetted Life Sciences start-ups

Bridge
Handshake
Person
alt

Pharmell Life Sciences offers a unique, specialized digital platform that not only connects early-stage, high-potential Life Sciences companies with diverse professional investors—from individuals to institutions—but also facilitates connections between investors.

Our platform provides streamlined fundraising support to promising early-stage Life Sciences companies that have undergone initial screening and independent scientific and regulatory due diligence. Investors gain access to curated investment opportunities and are also invited to propose their own start-ups for potential funding, broadening exposure and accelerating growth through a qualified investor network.


 

Pharmell Life Sciences: Your gateway to smarter early-stage Life Sciences investing.
Specialized Focus on Life Sciences

 

Our Life Sciences focus, backed by top-tier due diligence partners trusted by VCs, ensures investors access thoroughly vetted, high-integrity opportunities.

We connect. We guide. You grow.

 

Acting as facilitators, we help investors engage confidently by streamlining communication, ensuring transparency, and supporting every step from deal discovery to due diligence and beyond —saving you time, boosting clarity, and unlocking high-impact Life Sciences opportunities.

Smarter Investing, Together

 

Our platform goes beyond deal discovery—by connecting investors who share similar objectives. Whether it’s a specific therapeutic area, funding stage, or geographic focus, we help you co-invest with aligned peers to build stronger syndicates and amplify impact.

Unmatched Investment Terms

 

We offer investors free access to exclusive Life Sciences opportunities with no investment fees. If you invest, a disruptive 3% success fee is charged to the company— well below the usual 5–10% and gladly paid in return for investor access and capital.

Bring your start-up. Unlock co-investment.

 

As an investor, you can also propose your own promising start-ups for inclusion on the platform. Once approved through our independent due diligence process, these companies become visible to our investor network—unlocking co-investment opportunities, capital, and strategic support from peers who bring not just funding, but valuable industry expertise.

Our business model

As a Pharmell Life Sciences investor, you pay no membership fees, no due diligence fees, and no investment fees. If you decide to invest, a low 3% one-off success fee is charged to the company.

We believe your financial risk deserves full reward, so we don't take a share of your profits. That's why we charge no performance fee upon a successful exit.

Do you have any more questions?
Our experts are happy to help you